CapsoVision Reports Flat Q1 Revenue Amid Capsule Shipment Decline and Advances in AI Technology
CapsoVision reported $2.8 million in Q1 revenue, flat year-over-year, with capsule shipments declining by 3% due to order timing. The company highlighted ongoing investments in its pipeline and expects mid-year FDA clearance for an AI-assisted reading tool.
Topics: ai_in_healthcare fda_clearance medical_devices revenue_performance